Suchergebnisse - "Rader, Daniel J"

PubPharm (12)

1

The Role of Emerging Biomarkers in Unraveling the Complex Biology Underlying Associations between HDL Cholesterol and Cardiovascular Diseases

enthalten in: Clinical chemistry | 2017

von Small, A. | Mehta, N. | Rader, D.

CommentOn: Clin Chem. 2017 Jan;63(1):288-296. - PMID 27811210

2

The Role of Emerging Biomarkers in Unraveling the Complex Biology Underlying Associations between HDL Cholesterol and Cardiovascular Diseases

enthalten in: Clinical chemistry | 2017

von Small, A. | Mehta, N. | Rader, D.

3

Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteins

enthalten in: Clinical chemistry | 2014

von Lassman, M. | McAvoy, T. | Lee, A. | +9

4

Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins

enthalten in: Clinical chemistry | 2014

von Lassman, M. | McAvoy, T. | Lee, A. | +9

5

Beyond LDL cholesterol in assessing cardiovascular risk : apo B or LDL-P?

enthalten in: Clinical chemistry | 2013

von Master, S. | Rader, D.

CommentOn: Clin Chem. 2013 May;59(5):752-70. - PMID 23386699

6

Beyond LDL Cholesterol in Assessing Cardiovascular Risk: apo B or LDL-P?

enthalten in: Clinical chemistry | 2013

von Master, S. | Rader, D.

7

Measurement of fractional synthetic rates of multiple protein analytes by triple quadrupole mass spectrometry

enthalten in: Clinical chemistry | 2012

von Lee, A. | Yates, N. | Ichetovkin, M. | +14

8

Measurement of Fractional Synthetic Rates of Multiple Protein Analytes by Triple Quadrupole Mass Spectrometry

enthalten in: Clinical chemistry | 2012

von Lee, A. | Yates, N. | Ichetovkin, M. | +14

9

Phospholipidation of HDL--how much is too much?

enthalten in: Clinical chemistry | 2011

von Lagor, W. | Rader, D.

10

Phospholipidation of HDL-How Much Is Too Much?

enthalten in: Clinical chemistry | 2011

von Lagor, W. | Rader, D.